Healthcare provider profile · identity verified

Farzana Matin

Hospitalist · BRONX, NY · NPI 1295979698

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	551	94
Atorvastatin Calcium	Atorvastatin Calcium	545	183
Gabapentin	Gabapentin	469	108
Levothyroxine Sodium	Levothyroxine Sodium	425	94
Pantoprazole Sodium	Pantoprazole Sodium	397	155
Amlodipine Besylate	Amlodipine Besylate	381	101
Furosemide	Furosemide	363	114
Losartan Potassium	Losartan Potassium	302	69
Metoprolol Tartrate	Metoprolol Tartrate	249	60
Tamsulosin Hcl	Tamsulosin Hcl	246	73
Metoprolol Succinate	Metoprolol Succinate	238	88
Metformin Hcl	Metformin Hcl	233	55
Mirtazapine	Mirtazapine	202	42
Escitalopram Oxalate	Escitalopram Oxalate	173	34
Oxycodone Hcl	Oxycodone Hcl	172	47
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	164	23
Lisinopril	Lisinopril	154	39
Levetiracetam	Levetiracetam	153	29
Hydralazine Hcl	Hydralazine Hcl	152	40
Latanoprost	Latanoprost	149	31
Simvastatin	Simvastatin	143	28
Carvedilol	Carvedilol	141	39
Clopidogrel	Clopidogrel Bisulfate	141	38
Quetiapine Fumarate	Quetiapine Fumarate	136	28
Famotidine	Famotidine	132	46
Finasteride	Finasteride	127	33
Lactulose	Lactulose	122	30
Xarelto	Rivaroxaban	120	32
Sertraline Hcl	Sertraline Hcl	117	30
Nystatin	Nystatin	110	41
Potassium Chloride	Potassium Chloride	105	31
Memantine Hcl	Memantine Hcl	101	17
Trazodone Hcl	Trazodone Hcl	99	26
Tramadol Hcl	Tramadol Hcl	95	31
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	93	48
Insulin Lispro Kwikpen U-100	Insulin Lispro	92	15
Prednisone	Prednisone	92	42
Sucralfate	Sucralfate	90	14
Torsemide	Torsemide	90	23
Risperidone	Risperidone	89	17
Allopurinol	Allopurinol	86	26
Donepezil Hcl	Donepezil Hcl	82	24
Jardiance	Empagliflozin	79	15
Ammonium Lactate	Ammonium Lactate	75	28
Divalproex Sodium	Divalproex Sodium	73	12
Enoxaparin Sodium	Enoxaparin Sodium	73	14
Ketoconazole	Ketoconazole	73	24
Clonazepam	Clonazepam	70	12
Olanzapine	Olanzapine	69	13
Triamcinolone Acetonide	Triamcinolone Acetonide	68	22
Aripiprazole	Aripiprazole	66	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	62	22
Santyl	Collagenase Clostridium Hist.	62	20
Warfarin Sodium	Warfarin Sodium	61	suppressed
Clozapine	Clozapine	60	suppressed
Montelukast Sodium	Montelukast Sodium	59	19
Pregabalin	Pregabalin	57	11
Albuterol Sulfate Hfa	Albuterol Sulfate	56	35
Baclofen	Baclofen	56	suppressed
Nifedipine Er	Nifedipine	55	13
Budesonide	Budesonide	54	20
Enalapril Maleate	Enalapril Maleate	53	14
Lorazepam	Lorazepam	52	suppressed
Omeprazole	Omeprazole	52	21
Midodrine Hcl	Midodrine Hcl	49	20
Silver Sulfadiazine	Silver Sulfadiazine	46	27
Ssd	Silver Sulfadiazine	45	19
Buspirone Hcl	Buspirone Hcl	44	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	43	29
Ciprofloxacin Hcl	Ciprofloxacin Hcl	43	27
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	43	13
Citalopram Hbr	Citalopram Hydrobromide	42	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	42	12
Labetalol Hcl	Labetalol Hcl	42	suppressed
Clobetasol Propionate	Clobetasol Propionate	41	15
Spironolactone	Spironolactone	41	22
Colchicine	Colchicine	39	11
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	38	suppressed
Piperacillin-Tazobactam	Piperacillin Sodium/Tazobactam	38	26
Alendronate Sodium	Alendronate Sodium	37	suppressed
Amiodarone Hcl	Amiodarone Hcl	37	suppressed
Diclofenac Sodium	Diclofenac Sodium	37	16
Januvia	Sitagliptin Phosphate	37	suppressed
Mupirocin	Mupirocin	37	19
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	37	14
Carbidopa-Levodopa	Carbidopa/Levodopa	36	13
Clonidine Hcl	Clonidine Hcl	36	suppressed
Ondansetron Hcl	Ondansetron Hcl	36	30
Benztropine Mesylate	Benztropine Mesylate	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	suppressed
Alprazolam	Alprazolam	34	13
Hydrocortisone	Hydrocortisone	34	14
Lacosamide	Lacosamide	33	suppressed
Atenolol	Atenolol	32	13
Celecoxib	Celecoxib	32	14
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Retacrit	Epoetin Alfa-Epbx	32	suppressed
Creon	Lipase/Protease/Amylase	30	suppressed
Scopolamine	Scopolamine	30	suppressed
Valsartan	Valsartan	30	suppressed
Azithromycin	Azithromycin	29	16
Entresto	Sacubitril/Valsartan	29	12
Linzess	Linaclotide	29	suppressed
Methenamine Hippurate	Methenamine Hippurate	29	suppressed
Morphine Sulfate	Morphine Sulfate	29	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	29	28
Pravastatin Sodium	Pravastatin Sodium	29	suppressed
Brilinta	Ticagrelor	28	suppressed
Nystop	Nystatin	28	13
Timolol Maleate	Timolol Maleate	28	suppressed
Glipizide	Glipizide	27	suppressed
Glimepiride	Glimepiride	26	suppressed
Xigduo Xr	Dapaglifloz Propaned/Metformin	26	suppressed
Bumetanide	Bumetanide	25	11
Sildenafil Citrate	Sildenafil Citrate	24	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	14
Duloxetine Hcl	Duloxetine Hcl	23	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	23	suppressed
Levofloxacin	Levofloxacin	23	18
Repaglinide	Repaglinide	23	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	23	suppressed
Ceftriaxone	Ceftriaxone Sodium	22	18
Dorzolamide Hcl	Dorzolamide Hcl	22	suppressed
Dropsafe Pen Needle	Pen Needle, Diabetic, Safety	22	suppressed
Sodium Chloride	0.9 % Sodium Chloride	22	15
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	21	suppressed
Movantik	Naloxegol Oxalate	21	suppressed
Veltassa	Patiromer Calcium Sorbitex	21	suppressed
Albuterol Sulfate	Albuterol Sulfate	20	suppressed
Bethanechol Chloride	Bethanechol Chloride	20	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Mupirocin	Mupirocin Calcium	20	suppressed
Rexulti	Brexpiprazole	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Cephalexin	Cephalexin	19	16
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Symbicort	Budesonide/Formoterol Fumarate	19	suppressed
Alogliptin	Alogliptin Benzoate	18	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	18	18
Brimonidine Tartrate	Brimonidine Tartrate	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	suppressed
Diltiazem Hcl	Diltiazem Hcl	18	suppressed
Fluconazole	Fluconazole	18	suppressed
Insulin Lispro	Insulin Lispro	18	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Vancomycin Hcl	Vancomycin Hcl	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Megestrol Acetate	Megestrol Acetate	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Securesafe Pen Needle	Pen Needle, Diabetic, Safety	17	suppressed
Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Metronidazole	Metronidazole	16	suppressed
Primidone	Primidone	16	suppressed
Topiramate	Topiramate	16	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Alphagan P	Brimonidine Tartrate	15	suppressed
Amantadine	Amantadine Hcl	15	suppressed
Dorzolamide-Timolol	Dorzolamide/Timolol/Pf	15	suppressed
Fluticasone Propionate	Fluticasone Propionate	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Seroquel Xr	Quetiapine Fumarate	15	suppressed
Xtampza Er	Oxycodone Myristate	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Haloperidol	Haloperidol	14	suppressed
Ingrezza	Valbenazine Tosylate	14	suppressed
Methadone Hcl	Methadone Hcl	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Oxycontin	Oxycodone Hcl	14	suppressed
Premarin	Estrogens, Conjugated	14	suppressed
Procrit	Epoetin Alfa	14	suppressed
Xcopri	Cenobamate	14	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	13	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	13	suppressed
Diazepam	Diazepam	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Methimazole	Methimazole	13	suppressed
Sps	Sodium Polystyrene Sulfon/Sorb	13	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	12	suppressed
Enulose	Lactulose	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Meropenem	Meropenem	12	suppressed
Perphenazine	Perphenazine	12	suppressed
Prasugrel Hcl	Prasugrel Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Solu-Medrol	Methylprednisolone Sod Succ/Pf	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Asenapine Maleate	Asenapine Maleate	11	suppressed
Cefepime Hcl	Cefepime Hcl	11	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Telmisartan	Telmisartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error